Priscilla Novak1, Kenneth A Feder2, Mir M Ali3, Jie Chen4. 1. University of Maryland, College Park, School of Public Health, Department of Health Services Administration, 4200 Valley Drive #2242, College Park, MD 20847, United States of America. Electronic address: pnovak1@umd.edu. 2. Johns Hopkins University, Bloomberg School of Public Health, United States of America. 3. Office of the Assistant Secretary for Planning & Evaluation, US Department of Health & Human Services, United States of America. 4. University of Maryland, College Park, School of Public Health, United States of America.
Abstract
BACKGROUND: Past research shows that among individuals with substance use disorders, the presence of a co-occurring mental illness can influence the initiation, course, and success of behavioral health treatment, but little research has examined people with opioid use disorder (OUD) specifically. METHODS: Using the 2008-2014 National Survey on Drug Use and Health, this study examines the utilization of substance use disorder and mental health treatment among individuals with OUD and different degrees of mental illness severity. The study also examined types of treatment, perceived unmet need for treatment, and barriers to care. RESULTS: 47% of individuals with OUD and co-occurring mild/moderate mental illness did not receive any behavioral health treatment, and 21% of those with co-occurring serious mental illnesses did not receive any behavioral health treatment. Among those with OUD and co-occurring mild/moderate mental illness, 16% reported receiving both substance use disorder and mental health treatment; among those with co-occurring serious mental illness the rate was 32%. The most common form of treatment was prescription medication for mental health, and this was true regardless of whether or not the individual had any mental illness. More than 50% of the study population reported financial difficulties as a barrier to treatment. CONCLUSION: A high proportion of individuals with OUD and co-occurring mental illness are not receiving needed care. However, nearly one in five of those with OUD but no diagnosed mental illness is receiving prescription medication for mental illness. These findings suggest that there is a need to better facilitate access to and coordinate behavioral health care across settings for individuals with OUD. Published by Elsevier Inc.
BACKGROUND: Past research shows that among individuals with substance use disorders, the presence of a co-occurring mental illness can influence the initiation, course, and success of behavioral health treatment, but little research has examined people with opioid use disorder (OUD) specifically. METHODS: Using the 2008-2014 National Survey on Drug Use and Health, this study examines the utilization of substance use disorder and mental health treatment among individuals with OUD and different degrees of mental illness severity. The study also examined types of treatment, perceived unmet need for treatment, and barriers to care. RESULTS: 47% of individuals with OUD and co-occurring mild/moderate mental illness did not receive any behavioral health treatment, and 21% of those with co-occurring serious mental illnesses did not receive any behavioral health treatment. Among those with OUD and co-occurring mild/moderate mental illness, 16% reported receiving both substance use disorder and mental health treatment; among those with co-occurring serious mental illness the rate was 32%. The most common form of treatment was prescription medication for mental health, and this was true regardless of whether or not the individual had any mental illness. More than 50% of the study population reported financial difficulties as a barrier to treatment. CONCLUSION: A high proportion of individuals with OUD and co-occurring mental illness are not receiving needed care. However, nearly one in five of those with OUD but no diagnosed mental illness is receiving prescription medication for mental illness. These findings suggest that there is a need to better facilitate access to and coordinate behavioral health care across settings for individuals with OUD. Published by Elsevier Inc.
Entities:
Keywords:
Barriers to care; Mental health; Mental health treatment; Opioids; Substance use disorder treatment
Authors: D S Bender; R T Dolan; A E Skodol; C A Sanislow; I R Dyck; T H McGlashan; M T Shea; M C Zanarini; J M Oldham; J G Gunderson Journal: Am J Psychiatry Date: 2001-02 Impact factor: 18.112
Authors: Olatz Garin; Jose Luis Ayuso-Mateos; Josué Almansa; Marta Nieto; Somnath Chatterji; Gemma Vilagut; Jordi Alonso; Alarcos Cieza; Olga Svetskova; Helena Burger; Vittorio Racca; Carlo Francescutti; Eduard Vieta; Nenad Kostanjsek; Alberto Raggi; Matilde Leonardi; Montse Ferrer Journal: Health Qual Life Outcomes Date: 2010-05-19 Impact factor: 3.186
Authors: James H Ford; Arveen Kaur; Deepika Rao; Aaron Gilson; Daniel M Bolt; Helene Chokron Garneau; Lisa Saldana; Mark P McGovern Journal: Implement Res Pract Date: 2021-09-17
Authors: James H Ford; Deepika Rao; Aaron Gilson; Arveen Kaur; Helene Chokron Garneau; Lisa Saldana; Mark P McGovern Journal: J Dual Diagn Date: 2022-04-07
Authors: Alissa Davis; Andrea Norcini Pala; Louisa Gilbert; Phillip L Marotta; Dawn Goddard-Eckrich; Nabila El-Bassel Journal: Int J Drug Policy Date: 2020-07-09
Authors: Catherine Tomko; Kristin E Schneider; Saba Rouhani; Glenna J Urquhart; Ju Nyeong Park; Miles Morris; Susan G Sherman Journal: Addict Behav Date: 2021-12-20 Impact factor: 4.591
Authors: Francisco A Montiel Ishino; Philip R McNab; Tamika Gilreath; Bonita Salmeron; Faustine Williams Journal: BMC Public Health Date: 2020-11-18 Impact factor: 3.295